Skip to main content

Table 5 An updated summary of MN patents

From: Emerging era of microneedle array for pharmaceutical and biomedical applications: recent advances and toxicological perspectives

Sr. No.

Publication number

Conditions or diseases

Description/summary

Ref.

1.

13/2019

201811044930

Electrochemical biosensing in body fluid

In this invention, it has developed a modern method for MNs that prints assembled screens. Electrode fixes the biosensing electrode to print the screen that sensing of blood glucose, cholesterol HbA1C and like.

[22]

2.

48/2018

201721017985

Treatment of hyperkeratosis, injury, and pain in conditions like warts, corns, calluses, acne, psoriasis, keloids, microtrauma, eczema

The MNs patches based topical drug delivery system incorporated with keratolytic agents. The patch comprises micron-scale protrusions that penetrate via the SC and delivers the active pharmaceutical ingredient across the SC to improve the permeation of drugs. A keratolytic agent reduces the intercellular cohesiveness of the horny cells and thus enables speedy shedding of keratinized cells.

[23]

3.

42/2018

2017201721013027

Management of anxiety

In this patent novel, the buspirone microemulsion method has developed using the phase titration method and tested for its efficiency in the skin. It enhances transdermal delivery.

[24]

4.

WO/2010/013601

Enhancement of immunogenicity

It has enhanced immunogenicity using an MNs for the Japanese encephalitis virus antigen derived from kidney cells of monkey and concluded that antibody against a Japanese encephalitis virus antigen has efficiently enhanced.

[146]

5.

WO/2010/001671

Enhancing the immunogenicity against influenza virus

Polylactic acid-coated MNs of an influenza vaccine that is the H1N1 strain, H3N2 and types B strain, and brought into direct skin contact that enhances immunogenicity against influenza virus.

[147]

6.

20150290163

To treat pimples, stains, or wrinkles

MNs contains a substrate, water-swelling polymer, and retinoic acid. It dissolves in an enormous amount of water.

[148]

7.

20200170940

Local anesthesia

The invention provides immediate acting local anesthetic MNs easily applied to the oral cavity or site, In which a needle part dissolves in a mucous membrane when applying to an oral mucous membrane or gums.

[149]

8.

20170209553

Botulinum toxin to treat diseases

To treat disease, disorder, or condition therapeutic amount of toxin was added to the MN array

[150]

9.

20100030100

Diagnosis of allergy

This is an invention of a diagnostic MN device for the detection of an allergy. It holds at least one allergen that enables to perform skin tests with an effortless process in the diagnosis of allergies. These MNs have been prepared using non-metallic synthetic or natural resin material.

[151]